Authors

• Elisa V. Bandera (ORCID: https://orcid.org/0000-0002-8789-2755)
• Chi‐Chen Hong (ORCID: https://orcid.org/0000-0001-9212-2264)
• Mario Schootman (ORCID: https://orcid.org/0000-0003-1162-8824)
• Stephen John Mooney (ORCID: https://orcid.org/0000-0001-9092-938X)
• Nur Zeinomar (ORCID: https://orcid.org/0000-0001-8219-8599)
• Bo Qin (ORCID: https://orcid.org/0000-0003-2110-6050)
• Christine B. Ambrosone (ORCID: https://orcid.org/0000-0003-1717-9943)
• Kitaw Demissie (ORCID: https://orcid.org/0000-0002-0554-714X)
• Jesse J. Plascak (ORCID: https://orcid.org/0000-0002-4277-2987)
• Adana A. M. Llanos (ORCID: https://orcid.org/0000-0001-9954-9121)
• Karen Pawlish (ORCID: https://orcid.org/0000-0001-9019-8804)
• Hari S. Iyer (ORCID: https://orcid.org/0000-0002-7596-9049)
• Andrew Graham Rundle (ORCID: https://orcid.org/0000-0003-0211-7707)
• Cathleen Y. Xing

Institutions

• Rutgers, The State University of New Jersey (US)
• Roswell Park Comprehensive Cancer Center (US)
• New Jersey Department of Health (US)
• SUNY Downstate Health Sciences University (US)
• University of Washington (US)
• Columbia University Irving Medical Center (US)
• San Francisco Department of Public Health (US)
• Rutgers Cancer Institute (US)
• The Ohio State University (US)
• Columbia University (US)
• University of Arkansas at Fayetteville (US)
• University of Arkansas for Medical Sciences (US)

Publication Details

Journal

Cancer Epidemiology Biomarkers & Prevention

Published

2025-02-20

DOI

https://doi.org/10.1158/1055-9965.epi-24-1184

Citations

4

Primary Topic

Global Cancer Incidence and Screening

Type

article

Field-Weighted Citation Impact

4.18

Funders

• Rutgers Cancer Institute of New Jersey
• National Institutes of Health
• Centers for Disease Control and Prevention
• National Cancer Institute